<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by KeithPowers on Medium]]></title>
        <description><![CDATA[Stories by KeithPowers on Medium]]></description>
        <link>https://medium.com/@keithpowers?source=rss-bcfc35eced1b------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/0*7zmwjKHuBS5fWYqe.jpeg</url>
            <title>Stories by KeithPowers on Medium</title>
            <link>https://medium.com/@keithpowers?source=rss-bcfc35eced1b------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sun, 22 Nov 2026 16:43:40 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@keithpowers/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[$1,000,000 LONGEVITY PRIZE]]></title>
            <link>https://medium.com/@keithpowers/1-000-000-longevity-prize-10-teams-let-s-go-6fa0a3627fb5?source=rss-bcfc35eced1b------2</link>
            <guid isPermaLink="false">https://medium.com/p/6fa0a3627fb5</guid>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[research]]></category>
            <dc:creator><![CDATA[KeithPowers]]></dc:creator>
            <pubDate>Fri, 11 Mar 2016 01:18:28 GMT</pubDate>
            <atom:updated>2016-03-15T17:13:07.796Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*XanBM2bOM8ZNYlySn_bGJg.jpeg" /></figure><p><strong>$1,000,000 LONGEVITY PRIZE + 10 TEAMS = LET’S GO!</strong></p><p>On September 9, 2014 we announced the <a href="http://paloaltoprize.com/">Palo Alto Prize</a>, a $1M initiative to foster innovations that will ultimately help people live significantly healthier and longer lives as a result of better health. The initiative was designed to have two parts, a <a href="http://paloaltoprize.com/prize-one/">$500,000 Longevity Demonstration Prize </a>and a<a href="http://paloaltoprize.com/prize-two/"> $500,000 Homeostatic Capacity Prize</a>.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2Fay_6qRevo_8%3Ffeature%3Doembed&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3Day_6qRevo_8&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2Fay_6qRevo_8%2Fhqdefault.jpg&amp;key=d04bfffea46d4aeda930ec88cc64b87c&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/b973050a670b574362feb23af8b6e316/href">https://medium.com/media/b973050a670b574362feb23af8b6e316/href</a></iframe><p>Historically, <a href="http://paloaltoprize.com/wp-content/uploads/2014/09/Prizes_White_House_TheCraftofIncentivePrizeDesign.pdf">incentive prizes</a> have proven to be a very effective tool to foster innovation in specific areas of science and discovery. They create problem-solving ecosystems. The ecosystem works because the prize purse and target pull innovation towards a specific goal while also attracting minds, media and money to help push from all sides. When all cylinders are firing amazing things can happen, entire industries can be created, we discover new heroes, and public opinion changes forever.</p><p><strong>Today, we are excited to announce the names of the ten teams that have officially registered for the $500,000 Palo Alto Longevity Demonstration Prize</strong>, a three year global competition co-created and sponsored by Dr. Joon Yun that challenges teams from all over the world to “hack the aging code” to improve our health and extend lifespan<strong>.</strong></p><p><strong>Here is a quick intro video about the prize:</strong></p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2Fepy6CEHRRHI%3Ffeature%3Doembed&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3Depy6CEHRRHI%26feature%3Dyoutu.be&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2Fepy6CEHRRHI%2Fhqdefault.jpg&amp;key=d04bfffea46d4aeda930ec88cc64b87c&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/55e755ec00b5674b52f8d93d7333eadc/href">https://medium.com/media/55e755ec00b5674b52f8d93d7333eadc/href</a></iframe><p>Each of the<a href="http://paloaltoprize.com/prize-one/"> 10 teams</a> (listed below with videos of their approaches) are from top universities and private labs from North America and all over the world. They have a wide range of proposed approaches to win the prize including (but not limited to) stem cells, genetic modification, modified messenger RNA encoding telomerase, modulation of peripheral metabolism, PAI-1 signaling, antioxidants/free radicals, and manipulation of nested biorhythms. The first of the following ten teams to demonstrate a method of extending the lifespan of an animal by 50% will win the prize.</p><p><strong>We would like to thank </strong><a href="http://www.drjoonyun.com/"><strong>Dr. Joon Yun</strong></a><strong> for his support and leadership in launching this effort.</strong> Without visionary philanthropists like Dr. Yun prizes like the Palo Alto Prize would not be possible. Dr. Yun is the President of Palo Alto Investors, LLC and the founder of the Palo Alto Institute, a nonprofit think-tank that has been providing operational support for the Palo Alto Prize. As a medical doctor and healthcare investor, Dr. Yun has a unique perspective into medicine and the state of the industry. And while he believes that the current healthcare system is doing a remarkable job of addressing the diseases of aging, he helped launch the prize because he believes that “Addressing the diseases of aging without solving the underlying process of aging produces escalating effects on health care spending.”</p><p>We created the Race Against Time Foundation in order to raise public awareness and financial support for basic biomedical research related to increasing our health span and defining the fundamental biological mechanisms that prevent age-related diseases and disabilities. Based on the exponential rate of medical breakthroughs,<strong> </strong>we believe the question is not <em>if</em> we can crack the aging code and solve all major health challenges — but <em>when</em> will it happen. We are in a race against time and it is up to us if to decided if that timeframe is 5 years, 50 years or 500 years.</p><p><strong>What can you do to get involved?</strong></p><p>The best way that you can get involved is to support science and support the scientists. Take a look at each of our team profiles and reach out to them directly. Every day millions of scientists work to make our lives better. They are society’s real super heroes. These heroes work tirelessly to create and design everything around us, from rocket ships, to clean water filters, to cures for disease. Many of these heroes (like our teams) are dedicating their lives to research that will lead to discoveries that will increase our health span by helping us all live healthier and longer lives. Please support a scientist today!</p><p>We are excited to see what the teams come up with, but we also know that this prize is just one shot on goal. We encourage more public and private prizes and other industry efforts to help move the industry forward.</p><p>Keith Powers<br><em>Founder</em><br><a href="http://herosf.org/">Race Against Time &amp; Hero Science Foundation</a></p><p>PS. We would also like to thank all of our <a href="http://paloaltoprize.com/advisors">amazing advisors</a> who helped make this prize possible and who lend their time and their names to move the longevity field forward. <em>Full list at the end of this post below.</em></p><p><strong>— — — <br>Teams participating in the Longevity Demonstration Prize:<br> — — —</strong></p><p><a href="http://paloaltoprize.com/team/team-taylor-lab/">THI REGENERATIVE RESEARCH TEAM</a></p><blockquote><strong><em>“Now is the time to launch this prize because we have reached the point in science where we really do have the opportunity to solve aging,”</em> </strong>Doris Taylor, Ph.D</blockquote><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2Fv8CTnc11d28%3Ffeature%3Doembed&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3Dv8CTnc11d28%26feature%3Dyoutu.be&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2Fv8CTnc11d28%2Fhqdefault.jpg&amp;key=d04bfffea46d4aeda930ec88cc64b87c&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/60122a291cc6fdf222f85a4d30d12cf9/href">https://medium.com/media/60122a291cc6fdf222f85a4d30d12cf9/href</a></iframe><p><a href="http://paloaltoprize.com/team/houston-methodist-center-for-cardiovascular-regeneration/">Houston Methodist Center for Cardiovascular Regeneration</a></p><blockquote><em>“The Palo Alto Prize has galvanized our scientific community to think hard about how our fundamental insights into the mechanisms of aging can be leveraged toward transformative therapies.”</em> John P. Cooke, M.D., Ph.D.</blockquote><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FP_bgH9pBYDA%3Ffeature%3Doembed&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DP_bgH9pBYDA%26feature%3Dyoutu.be&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FP_bgH9pBYDA%2Fhqdefault.jpg&amp;key=d04bfffea46d4aeda930ec88cc64b87c&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/9fd54a0b5bbd8dcc6b8adec05cedae94/href">https://medium.com/media/9fd54a0b5bbd8dcc6b8adec05cedae94/href</a></iframe><p><a href="http://paloaltoprize.com/team/ajochhand/">AjoChhand</a></p><blockquote><em>“The Palo Alto Prize has galvanized our scientific community to think hard about how our fundamental insights into the mechanisms of aging can be leveraged toward transformative therapies.” </em>Anirban Bandyopadhyay, Ph.D.</blockquote><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FAzOxexy0Y10%3Ffeature%3Doembed&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DAzOxexy0Y10%26feature%3Dyoutu.be&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FAzOxexy0Y10%2Fhqdefault.jpg&amp;key=d04bfffea46d4aeda930ec88cc64b87c&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/bcc9daa21cb162a277dff6913e0b1fb4/href">https://medium.com/media/bcc9daa21cb162a277dff6913e0b1fb4/href</a></iframe><p><a href="http://paloaltoprize.com/team/sekhar-lab/">SEKHAR LAB</a></p><blockquote><em>“We are excited to be part of the Palo Alto Longevity Competition. The true prize is longevity, and we are sure that through the collective efforts of all teams, this will be a win for humankind”.</em> Rajagopal V Sekhar, M.D.</blockquote><p><a href="http://paloaltoprize.com/team/toor-lab/">Toor Lab</a></p><blockquote>“We now have the tools of molecular biology to treat the biochemical basis of aging by targeting many of the known pathways involved in this process.” Navtej Toor, Ph.D.</blockquote><p><a href="http://paloaltoprize.com/team/team-paithon/">Vaughan Lab</a></p><blockquote><em>“The biology of aging is becoming more evident every day that goes by. We are understanding that there are specific changes about cells and tissues as they age, and that there are markers that aging cells make and it’s possible to identify those molecules and theoretically slow down the aging process.” </em>Douglas E Vaughan, M.D.</blockquote><ul><li><a href="http://paloaltoprize.com/team/generation-x/">Generation X</a></li><li><a href="http://paloaltoprize.com/team/sun-lab/">SUN LAB</a></li></ul><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FeiOyi3gl33E%3Ffeature%3Doembed&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DeiOyi3gl33E%26feature%3Dyoutu.be&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FeiOyi3gl33E%2Fhqdefault.jpg&amp;key=d04bfffea46d4aeda930ec88cc64b87c&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/b491236afa2fa5875fb0f1946256edb3/href">https://medium.com/media/b491236afa2fa5875fb0f1946256edb3/href</a></iframe><ul><li><a href="http://paloaltoprize.com/team/dinostem/">DINOSTEM</a></li><li><a href="http://paloaltoprize.com/team/munich/">MUNICH</a></li></ul><blockquote>“Next generation cell-based therapies delivering therapeutic agents to impaired organs may change the life of many people.” <em>Christine Guenther, M.D.</em></blockquote><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2F7ycxqcmrIEM%3Ffeature%3Doembed&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3D7ycxqcmrIEM%26feature%3Dyoutu.be&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2F7ycxqcmrIEM%2Fhqdefault.jpg&amp;key=d04bfffea46d4aeda930ec88cc64b87c&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/191735b2b264c8d3a6e4d463bd3dc875/href">https://medium.com/media/191735b2b264c8d3a6e4d463bd3dc875/href</a></iframe><p><strong>— — — <br>Advisors to the Longevity Demonstration Prize:</strong><br><strong> — — — <br></strong>DAVID ARRINGTON, Chief Branding Officer, Stanford Medicine<br>SONIA ARRISON, Author, 100 Plus<br>BEN BARRES, M.D., Ph.D., Chairman, Department of Neurobiology, Stanford University<br>JEAN-JACQUES BIENAIME, CEO, Biomarin<br>ALBERT CHA, Managing Partner, Vivo Ventures<br>STACEY CHANG, Director, Healthcare Practice at IDEO<br>CHARLES CHO, M.D., Professor of Neurology and Neurosurgery, Stanford University<br>CASPER DECLERCQ, Partner, Norwest Ventures<br>AUBREY DE GREY, Ph.D, Chief Science Officer, SENS Foundation<br>LAURA DEMING, Founder, Longevity Fund<br>KERRY DOLAN, Assistant Managing Editor, Forbes<br>JAMES DOTY, M.D., Professor of Neurosurgery, Stanford University Founder and Director of CCARE<br>FREDERICK DOTZLER, Managing Director, De Novo Ventures<br>VICTOR DZAU, M.D., President, National Academy of Medicine, National Academy of Sciences<br>PATRICK ENRIGHT, Founder and Managing Director, Longitude Capital<br>FRANK FISCHER, President and CEO, Neuropace, Inc.<br>JIM GLASHEEN, Ph.D.,General Partner, Technology Partners<br>JANELL GOTTESMAN, Founder Physio-Insight and Milieu Institute<br>BOB HARRINGTON, M.D., Chairman, Department of Medicine, Stanford University<br>STEVE HERROD, Managing Director, General Catalyst Partners<br>HOYOUNG HUH, Managing Director, Konus Advisory Group<br>WAYNE JONAS, M.D., former Chief of the Office of Alternative Medicine, NIH<br>REESE JONES, Associate Founder, Singularity University; Trustee, Santa Fe Institute<br>STEVE JURVETSON, Managing Director, Draper Fisher Jurvetson<br>NINA KJELLSON, Managing Director, Interwest Ventures<br>GARHENG KONG, M.D., MBA, Managing General Partner, Sofinova Ventures<br>FRANK LONGO, M.D., Chairman, Department of Neurology &amp; Neurological Sciences, Stanford University<br>JOSH MAKOWER, M.D., Founder and CEO, ExploraMed<br>MICHAEL MCCULLOUGH, M.D., Principal, Capricorn Healthcare &amp; Special Opportunities<br>DAN MOORE, President and CEO, Cyberonics, Inc.<br>BARBARA NATTERSON-HOROWITZ, M.D., Professor of Medicine, UCLA Division of Cardiology<br>OLEG NODELMAN, Managing Partner, EcoR1 Capital<br>GUY P. NOHRA, Co-Founder and Managing Director, Alta Partners<br>KEITH POWERS, President, Engaged Partners, Former EVP of Strategy, X PRIZE Foundation<br>ROGER J. QUY, Ph.D., General Partner, Technology Partners<br>LEIGHTON READ, MD, Venture Partner, Alloy Ventures, Trustee, Santa Fe Institute<br>AMIR RUBIN, President and CEO of Stanford Hospital &amp; Clinic<br>GRAHAM SPENCER, General Partner, Google Ventures, Trustee, Santa Fe Institute<br>KEVIN STARR, Partner, Third Rock Ventures<br>CAMI SAMUELS, Partner, Venrock<br>STEVE VASSALLO, General Partner, Foundation Capital<br>CHARLES WARDEN, Managing Director, Versant Ventures<br>ERIC WEINSTEIN, Managing Director, Thiel Capital</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6fa0a3627fb5" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>